68 Ga-Pentixafor Uptake in Collecting Duct Carcinoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40644580.
- Also identified by DOI 10.1097/RLU.0000000000006050.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Collecting duct carcinoma (CDC), also known as Bellini duct carcinoma, is a highly aggressive and extremely rare subtype of renal cell carcinoma. Previous studies have suggested that CDC generally exhibits low CXCR4 expression, leading to negative or weak 68 Ga-pentixafor uptake. However, we report a case of 68 Ga-Pentixafor uptake in CDC on PET/CT. This finding challenges the conventional understanding of chemokine characteristics in CDC and underscores the importance of tumor heterogeneity, potentially providing new insights for precision treatment strategies.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms